Navigation Links
One-Third of Patients Discontinue Common Breast Cancer Therapy

PRINCETON, N.J.--(BUSINESS WIRE)--Mar 15, 2007 - An alarming study that appeared in the March 1, 2007 issue of CANCER (a peer-reviewed journal of the American Cancer Society), reports that one-third of women taking the standard five-year regimen of the hormonal breast cancer treatment tamoxifen citrate, discontinue therapy early.(1)

According to the authors, non-compliance with tamoxifen tablets is a major issue that may negatively affect treatment efficacy. While tamoxifen tablets remain a standard of care, according to these data, they are associated with compliance and persistency issues. Oncologists need to identify those at risk of non-persistence and develop strategies to combat this barrier to treatment success.

Patients at risk of non-persistence include those who prefer alternative delivery formats to traditional pills/tablets, such as liquid formulations. SOLTAMOX, the only liquid form of tamoxifen citrate, is an alternative for women who require tamoxifen therapy. SOLTAMOX may be an attractive option for women who do not like pills or cannot swallow pills. SOLTAMOX is approved by the FDA and is available in the U.S. through Cytogen Corporation. For more information about SOLTAMOX, please visit www.soltamoxus.com. -0-

WHO:   Linda Vahdat, MD, Weill Cornell Medical Center. Dr. Vahdat is a

        leading breast cancer expert and a participant in the

        Compliance Strategic Initiative -- a program designed to

        increase awareness compliance and to raise awareness

        importance of hormonal therapy in breast cancer.


WHAT:  Dr. Vahdat is available to speak with media regarding the

        importance of tamoxifen compliance and the need to offer

        patients more options.


WHEN:  March 2007


WHERE: Please contact Eliza Schleifstein (973) 387-0342 to set up a

        convenient time to interview Dr. Vahdat.

About SOLTAMOX

SOLTAMOX (tamoxifen c
'"/>




Page: 1 2 3

Related medicine technology :

1. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
2. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
3. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
4. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
5. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
6. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
7. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
8. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
9. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
10. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
11. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: One Third Patients Discontinue Common Breast Cancer Therapy
(Date:8/29/2014)... 2014   Mast Therapeutics, Inc. (NYSE ... that Santosh Vetticaden, Chief Medical Officer and Senior ... personal reasons, in mid-September.  Edwin L. Parsley ... Pharmaceuticals, which Mast acquired earlier this year, will ... interim Chief Medical Officer.  Dr. Parsley previously was ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "China Orthopedic Instrument Industry Report, 2014-2017" report to ... population and rising proportion of reimbursement for medical expenses, ... released, with its scale presenting a CAGR of 19.2% ... are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... Does your doctor know what you,re smoking?  Chances ... marijuana to the over 112,000 currently registered patients under ... the other roughly 20,300+ active physicians listed with the Colorado ... – even though a poll in February 2014 showed 51% ... tried it. "With marijuana legalization underway, every ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... Colo. , May 10 Heska Corporation (Nasdaq: HSKA ) today ... Wednesday, May 12, 2010 .  The presentation will be at The Intercontinental Hotel ... and is scheduled to begin at 9:55 a.m. Eastern Time . , ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) , ...
... May 10 Dr. Richard Hays ... diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled ... Phase III studies testing the safety and efficacy of an ... has completed enrollment of more than 530 subjects with type ...
Cached Medicine Technology:Protege Encore Clinical Trial Evaluates New Investigational Approach For Individuals Recently Diagnosed With Type 1 Diabetes 2
(Date:8/29/2014)... August 30, 2014 Skmen.com, a famous online ... sexy mini dresses . At the moment, all these ... percent off. The deadline of the promotion is September 14. ... clients with the latest information about our hot designs, we ... store. We hope to help all stylish ladies to get ...
(Date:8/29/2014)... Inc., a leading provider of scalable Asterisk-based contact center ... its Q-Suite 5.7 software. As a global provider ... deploying and supporting its ACD and Dialer software suite ... for more than a decade. The introduction of usage-based ... complements the widespread deployment of Q-Suite in the Cloud. ...
(Date:8/29/2014)... Developed as a nod to post-war ... Canada Goose products offer the mobility, durability and ... runways. The company’s Canada Goose Chilliwack bombers ... market. Additionally, the firm has unveiled its new bomber ... At present, all high quality Chilliwack bombers are provided ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 As reported by ... Monitoring For Drug Abuse Trends , Outbreaks (8/20), the National ... attempt to monitor drug abuse trends by turning to social ... drug abuse trends, it is also working with the University ... National Drug Early Warning System, which will be funded by ...
(Date:8/29/2014)... Formed in 2014, KAJ Brothers is a unique group ... Their sophisticated Pop/R&B sound, with beautiful orchestral elements is not ... experience every day. , The band has a ... with the primary purpose of elevating women with true love ... replied - “To make chivalry cool again, and help raise ...
Breaking Medicine News(10 mins):Health News:Cheap Sexy Mini Dresses Added To The Product Line Of Skmen.com 2Health News:Indosoft Offers Monthly Usage Licensing Terms 2Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 2Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 4
... Steven Reinberg HealthDay Reporter , TUESDAY, May 31 ... reduction in premiums and an easing of standards for the ... to get health insurance. Premiums under the Pre-Existing ... Act, will drop as much as 40 percent in 18 ...
... By Maureen Salamon HealthDay Reporter , ... studies linking genes, proteins and other so-called "biomarkers" with ... suggests. Analyzing 35 of the most frequently cited ... biomedical journals, study authors found that fewer than half ...
... A facelift incision and robotics can help surgeons safely ... patients without the characteristic neck scar. Georgia Health ... access capabilities of robots, experience gained from another no-neck-scar ... largest salivary gland from the lower jaw region. "It ...
... , TUESDAY, May 31 (HealthDay News) -- Violent ... according to a new University of Missouri study. ... become less responsive, or desensitized, to violence -- a ... "From a psychological perspective, video games are excellent teaching ...
... the 30 years since the first reported cases of ... made extraordinary advances in understanding, treating and preventing the ... National Institute of Allergy and Infectious Diseases (NIAID), part ... on those successes to control and, ultimately, end the ...
... , TUESDAY, May 31 (HealthDay News) -- As ... time with cyber time -- a trend leading one ... such as "sexting" and cyberbullying. "The Internet is a ... games and educational lessons, David Schwebel, a psychology professor at ...
Cached Medicine News:Health News:U.S. Makes It Easier to Get Insurance With Pre-Existing Conditions 2Health News:Tie Between 'Biomarkers,' Disease Often Overstated, Scientists Say 2Health News:Tie Between 'Biomarkers,' Disease Often Overstated, Scientists Say 3Health News:Facelift incision offers safe option for some thyroid patients 2Health News:Facelift incision offers safe option for some thyroid patients 3Health News:Violent Video Games Linked to Increased Aggression 2Health News:Parents Should Screen Kids' Summer Web Surfing: Expert 2
... Plate is a semi-rigid system intended ... The Slim-LOC is based on the ... current market technology. The Slim-LOC system ... instrumentation. Reduced width (16 mm), low ...
... is an Anterior Cervical Plating System ... flexibility and simplicity for the spinal ... function and safe fixation of the ... meet the needs of the spinal ...
... is intended for supportive stabilization of ... fusion. The device utilizes bi-cortical fixation ... is enhanced through dynamic screw holes ... single level interbody fusion. Anterior cervical ...
... designed to meet the clinical challenges of ... locking mechanism and the choice of fixed ... angle screws for ease of implantation in ... system allows the surgeon the versatility of ...
Medicine Products: